Kyriakou partner in ECOLEFINS EIC Pathfinder project
As a major contributor to the global CO2 emissions, the commodity chemical industry should be urgently coupled with renewable electricity to become independent from fossil fuel resources. ECOLEFINS aims to establish a new, all-electric paradigm for the electro-conversion of CO2 and H2O to light olefins; the key-intermediates for polymers, and other daily life chemical products. The project will introduce co-ionic ceramic membrane reactors while putting forward cutting-edge nanotechnology and engineering for the development of efficient electrodes and short-stacks in order to deliver RES-powered artificial photosynthesis of CO2 to valuable chemicals. This highly multi-disciplinary task synergies from the diverse fields of advanced materials science, electrochemical engineering, heterogeneous catalysis, multi-scale modelling, as well as sustainability assessment and marketization planning. ECOLEFINS is bringing together several partners across the EU, such as CERTH (GR), University of Groningen (NL), Juelich (GER), University of St. Andrews (UK) and Politecnico di Torino (ITA), with significant industrial involvement from ELCOGEN (FIN) and Hellenic Energy (GR).
The consortium received approximately 3M EURO of which 460.000 will go to Vassilis Kyriakou to primarily develop multifunctional and reversible electrocatalysts for the electrochemical reactors.
EIC Pathfinder
The poject Ecolefins was funded is in the context of EIC Pathfinder challenge 2022. With its Pathfinder programme the European Innovation Council (EIC) supports the exploration of bold ideas for radically new technologies. It welcomes the high-risk / high gain and interdisciplinary cutting-edge science collaborations that underpin technological breakthroughs. It is highly competitive with around 5% success rate.

Last modified: | 07 June 2023 12.09 p.m. |
More news
-
25 April 2025
Leading microbiologist Arnold Driessen honoured
On 25 April 2025, Arnold Driessen (Horst, the Netherlands, 1958) received a Royal Decoration. Driessen is Professor of Molecular Microbiology and chair of the Molecular Microbiology research department of the Faculty of Science and Engineering at the...
-
24 April 2025
Highlighted papers April 2025
The antimalarial drug mefloquine could help treat genetic diseases such as cystic fibrosis, Duchenne muscular dystrophy, as well as some cancers.
-
22 April 2025
Microplastics and their effects on the human body
Professor of Respiratory Immunology Barbro Melgert has discovered how microplastics affect the lungs and can explain how to reduce our exposure.